Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| MG | PRESS-RELEASE | neutral | 1/10 | MISTRAS Group CEO Natalia Shuman was named an honoree at the Executive Women of New Jersey Salute to the Policy Makers G | Oct 19, 2026 |
| AIOS | PRESS-RELEASE | bearish | 7/10 | AIOS Tech Inc. announces an all-stock acquisition of SmartCore Holdings Limited for approximately US$100 million, issuin | Oct 19, 2026 |
| ACU | PRESS-RELEASE | neutral | 1/10 | Acme United Corporation announced it will report its Q3 2026 results on October 27, 2026. | Oct 19, 2026 |
| SEZL | PRESS-RELEASE | neutral | 2/10 | Sezzle announced the launch of a Gen Z Advisory Council, a user feedback group of 30 members aged 18-25, to inform produ | Oct 19, 2026 |
| ONMD | PRESS-RELEASE | neutral | 3/10 | OneMedNet announced its 12th channel partner agreement with a leading global provider of pharmaceutical intelligence and | Oct 19, 2026 |
| SKYA | PRESS-RELEASE | mixed | 7/10 | SkyAI commenced a cash tender offer to purchase up to 95% of each class of its outstanding common stock and warrants at | Oct 19, 2026 |
| INDV | PRESS-RELEASE | neutral | 1/10 | Indivior Inc. announced it will report its Q3 2026 results. | Oct 19, 2026 |
| BELFA | PRESS-RELEASE | neutral | 1/10 | Bel Fuse Inc. announced it will host a conference call to discuss its Q3 2026 results. | Oct 19, 2026 |
| SUPN | PRESS-RELEASE | neutral | 1/10 | Supernus Pharmaceuticals, Inc. announced it will report its Q3 2026 results on October 29, 2026. | Oct 19, 2026 |
| EOSE | PRESS-RELEASE | bearish | 6/10 | Eos Energy Enterprises reported preliminary Q3 2026 revenue of $82-83M (169-172% YoY growth, above $81M consensus) but G | Oct 19, 2026 |
| RZAI | PRESS-RELEASE | neutral | 4/10 | Roze AI announced a non-binding MOA with Mullae District 3 Complex Development Co., Ltd. to evaluate participation in a | Oct 19, 2026 |
| DRTS | PRESS-RELEASE | bullish | 7/10 | Alpha Tau Medical announced FDA approval of an IDE supplement expanding its REGAIN trial for recurrent glioblastoma from | Oct 19, 2026 |
| XE | PRESS-RELEASE | bullish | 6/10 | X-energy (XE) announced a Joint Development Agreement with American Electric Power (AEP) to evaluate a 12-unit Xe-100 SM | Oct 19, 2026 |
| DWTX | PRESS-RELEASE | mixed | 5/10 | Dogwood Therapeutics announced a $5M private placement from its largest shareholder, CK Life Sciences, at $1.22/share (4 | Oct 19, 2026 |
| YMAT | PRESS-RELEASE | neutral | 4/10 | J-Star announced progress on its planned U.S. drone-frame production initiative, including negotiations to acquire a man | Oct 19, 2026 |
| CSW | PRESS-RELEASE | neutral | 1/10 | CSW Industrials, Inc. announced it will report its fiscal Q2 2027 results. | Oct 19, 2026 |
| ZONE | PRESS-RELEASE | bearish | 6/10 | Zone Frontier announced a 1-for-60 reverse stock split effective October 30, 2026, to regain NYSE American listing compl | Oct 19, 2026 |
| ENLV | PRESS-RELEASE | bearish | 6/10 | Enlivex announced a cost reduction plan to wind down non-clinical R&D, cut workforce by ~60%, and reduce management/CEO | Oct 19, 2026 |
| DAIO | PRESS-RELEASE | mixed | 6/10 | Data I/O Corporation announced the acquisition of V-TEK, Inc. and A&J Programming, Inc. for approximately $23 million in | Oct 19, 2026 |
| MKSI | PRESS-RELEASE | bullish | 6/10 | MKS Inc. agreed to sell its Ophir Optics business to TTM Technologies for $650 million in cash, representing over 18x pr | Oct 19, 2026 |
| TTMI | PRESS-RELEASE | bullish | 6/10 | TTM Technologies announced the acquisition of MKS Inc.'s Ophir Optics business for ~$650M in cash, adding high-precision | Oct 19, 2026 |
| VFS | PRESS-RELEASE | bullish | 6/10 | VinFast reported Q2 2026 EPS of -$0.02, a 94.6% beat vs consensus of -$0.37, on revenue of ~$1.2B (+85.5% YoY). EV deliv | Oct 19, 2026 |
| QTEX | PRESS-RELEASE | neutral | 3/10 | QTREX Quantum received Nasdaq notification confirming compliance with the minimum bid price rule after 10 consecutive tr | Oct 19, 2026 |
| CMT | PRESS-RELEASE | neutral | 1/10 | Core Molding Technologies, Inc. announced it will report its fiscal Q3 2026 results on November 3, 2026. | Oct 19, 2026 |
| HYPD | PRESS-RELEASE | neutral | 1/10 | Hyperion DeFi, Inc. announced it will host a conference call on November 12 to discuss its Q3 results. | Oct 19, 2026 |
| PHAT | PRESS-RELEASE | neutral | 1/10 | Phathom Pharmaceuticals announced it will report its Q3 2026 results on October 29, 2026. | Oct 19, 2026 |
| DAIO | PRESS-RELEASE | bearish | 6/10 | Data I/O Corporation announced a ~$13.25 million private placement of convertible subordinated debentures and common/pre | Oct 19, 2026 |
| ASML | PRESS-RELEASE | neutral | 2/10 | ASML reported its ongoing share buyback program transactions, a routine capital return activity with no material new inf | Oct 19, 2026 |
| NYXH | PRESS-RELEASE | bearish | 6/10 | Nyxoah reported preliminary Q3 2026 global net revenue of €9.2M (19% sequential growth) and U.S. net revenue of €6.7M (2 | Oct 19, 2026 |
| SGP | PRESS-RELEASE | bullish | 7/10 | SpyGlass Pharma announced positive 4-year first-in-human trial results for its Bimatoprost Drug Pad-IOL System, showing | Oct 19, 2026 |